NotizieBenzingaAscendis Pharma Receives Positive Opinion From Committee For Medicinal Products For Human Use Of European Medicines Agency For Marketing Authorization Of TransCon CNP In EU To Treat Achondroplasia Ascendis Pharma Receives Positive Opinion From Committee For Medicinal Products For Human Use Of European Medicines Agency For Marketing Authorization Of TransCon CNP In EU To Treat Achondroplasia Benzinga 2026.10.16 12:31 (GMT+0) Apri Benzinga Altre notizie Newline by Fifth Third lancia carte Visa aziendali in oltre 40 paesi Cognizant amplia la partnership con Google Cloud con 18.000 ingegneri Alaska Airlines nomina Amaresh Siva come chief information officer TSX in calo: l’inflazione riaccende i timori sui tassi, petrolio in ritirata Il CEO di Teradyne Gregory Smith vende azioni per $1,36 milioni La direttrice di Teradyne Marilyn Matz vende azioni per $273.024
